Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy
Dan Liu(Peking University), Zhaohui Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kongshuo Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuang Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuanwei Pan(National University of Singapore), Kaiqing Yun(Chinese Academy of Medical Sciences & Peking Union Medical College), Lang Rao(National Institutes of Health), Xiaoyuan Chen(Agency for Science, Technology and Research), Qian‐Fang Meng(Shenzhen Bay Laboratory), Jian Wei(Capital Medical University), Mengli Zhou(Central South University), Xingang Li(Capital University)
Cited by 108
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.3k
Majorbio Cloud: A one‐stop, comprehensive bioinformatic platform for multiomics analyses
|iMeta|2022|857
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|398
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
|Advanced Materials|2020|278